Preoperative diagnostic criteria for scleroatrophic gallbladder: A systematic review protocol

TL;DR

This paper outlines a systematic review protocol to establish preoperative diagnostic criteria for the rare condition scleroatrophic gallbladder.

Contribution

The study introduces a structured approach to evaluate and summarize diagnostic criteria and imaging modalities for scleroatrophic gallbladder.

Findings

The review will synthesize preoperative diagnostic criteria for scleroatrophic gallbladder.

It will assess the value of imaging studies in diagnosing the condition.

The work aims to guide doctors in decision-making for diagnosis and treatment.

Abstract

Although scleroatrophic gallbladder is a rare condition, it presents significant clinical challenges in diagnosis and management. More agreement is needed on this disorder’s diagnostic criteria and optimal management approach. We will conduct a systematic review to summarise the scleroatrophic gallbladder’s preoperative diagnostic criteria, including imaging modalities.

A systematic review will be undertaken using the PRISMA guidelines. The protocol has been registered in PROSPERO (CRD42024503701). We will search in Medline (via PubMed), Embase, SCOPUS, the Cochrane Library, and Web of Science to find original studies reporting about scleroatrophic gallbladder or synonymous. Two reviewers will independently screen the titles and abstracts following the eligibility criteria. We will include all types of studies that describe any diagnostic criteria or tools. After retrieving the full text of the selected studies, we will conduct a standardised data extraction. Finally, a narrative synthesis will be performed. The quality of the identified studies will be assessed using the Quality Assessment of Diagnostic Accuracy Studies- 2 tool.

This systematic review will provide information on the preoperative diagnostic criteria of the scleroatrophic gallbladder and the value of imaging studies in its diagnosis. In addition, this work will aid doctors in the decision-making process for diagnosing scleroatrophic gallbladder and propose treatment approaches to this condition.

The protocol has been registered in PROSPERO (CRD42024503701).